Clinical trials
Active, not recruiting Breast Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 13 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 14 |
| Eli Lilly and Company | 10 |
| Pfizer | 10 |
| Hoffmann-La Roche | 3 |
| Seagen, a wholly owned subsidiary of Pfizer | 3 |
| GlaxoSmithKline | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Alliance Foundation Trials, LLC. | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 57 |
| Neoplasm Metastasis | 10 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Colorectal Neoplasms | 6 |
| Neoplasms | 6 |
| Endometrial Neoplasms | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Head and Neck Neoplasms | 4 |
| Neoplasms by Site | 4 |
| Ovarian Neoplasms | 4 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.